0001209191-22-021458.txt : 20220329 0001209191-22-021458.hdr.sgml : 20220329 20220329161502 ACCESSION NUMBER: 0001209191-22-021458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220209 FILED AS OF DATE: 20220329 DATE AS OF CHANGE: 20220329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Suri Anish CENTRAL INDEX KEY: 0001739130 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 22780939 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-09 0 0001645460 Cue Biopharma, Inc. CUE 0001739130 Suri Anish C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 PRESIDENT AND CSO Stock Option (right to buy) 6.91 2022-02-09 4 A 0 82000 0.00 A 2032-02-08 Common Stock 82000 82000 D Stock Option (right to buy) 5.01 2022-03-25 4 A 0 21333 0.00 A 2032-03-24 Common Stock 21333 21333 D 1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022. 2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022. /s/ Anish Suri by Colin Sandercock, attorney-in-fact 2022-03-29